PD-L1 is an independent prognostic predictor in gastric cancer of Western patients

Targeting the PD-1/PD-L1 immune checkpoint signaling is a novel promising treatment strategy in several tumor entities, and it is suggested that PD-L1/PD-1 expression is predictive for a PD-1/PD-L1 checkpoint inhibitor treatment response. We investigated the expression of PD-L1 and PD-1 by immunohis...

Descripción completa

Detalles Bibliográficos
Autores principales: Böger, Christine, Behrens, Hans-Michael, Mathiak, Micaela, Krüger, Sandra, Kalthoff, Holger, Röcken, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029700/
https://www.ncbi.nlm.nih.gov/pubmed/27009855
http://dx.doi.org/10.18632/oncotarget.8169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029700/
https://www.ncbi.nlm.nih.gov/pubmed/27009855
http://dx.doi.org/10.18632/oncotarget.8169

Ejemplares similares